The Long-Haul Role of Laboratory Diagnostics Post-COVID
While the tide is turning on COVID-19, clinical labs will continue to test long-haulers and the effects of the virus for years to come.
Read MorePosted by Chris Wolski | May 20, 2021 | Covid 19 |
While the tide is turning on COVID-19, clinical labs will continue to test long-haulers and the effects of the virus for years to come.
Read MorePosted by Melanie Hamilton-Basich | May 18, 2021 | Accreditation, Molecular Diagnostics |
The Association for Molecular Pathology and the Association of Pathology Chairs have voiced their support for the Verified Innovative Testing in American Laboratories (VITAL) Act of 2021.
Read MorePosted by Melanie Hamilton-Basich | May 18, 2021 | Blood Banking, Sponsored
We are entering a pivotal moment in time in blood product inventory management. While optimizing blood supply inventory has always been a top priority, the COVID-19 pandemic has truly put blood banks to the test
Read MorePosted by Melanie Hamilton-Basich | May 11, 2021 | Molecular Diagnostics |
The study shows the kit provides comprehensive, reproducible detection of variants linked to spinal muscular atrophy for diagnostics and carrier screening using a simple workflow that produces results in less than four hours.
Read MorePosted by Melanie Hamilton-Basich | May 10, 2021 | Covid 19 |
Inova Diagnostics has received emergency use authorization for its Quanta Flash SARS-CoV-2 IgG for use on the Bio-Flash random access chemiluminescent analyzer from Biokit.
Read More